Impaired clearance of apoptotic cells in chronic inflammatory diseases: Therapeutic implications

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Szondy, Zsuzsa ^a   Garabuczi, Éva ^a   Joós, Gergely ^a   Tsay, Gregory J ^b   Sarang, Zsolt ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Apoptotic cell; Atherosclerosis; Autoimmunity; Inflammation; Obesity; Phagocytosis; Therapy; Type 2 diabetes

Indexed keywords

EID: 84905660553     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00354     Document Type: Short Survey

References (119)

1. Hart SP, Dransfield I, Rossi AG. Phagocytosis of apoptotic cells. Methods (2008) 44:280-5. doi: 10.1016/j.ymeth.2007.11.009
2. Rigamonti E, Zordan P, Sciorati C, Rovere-Querini P, Brunelli S. Macrophage plasticity in skeletal muscle repair. Biomed Res Int (2014) 2014:560629. doi:10.1155/2014/560629
3. Thorp EB. Contrasting inflammation resolution during atherosclerosis and post myocardial infarction at the level of monocyte/macrophage phagocytic clearance. Front Immunol (2012) 3:39. doi:10.3389/fimmu.2012.00039
4. Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res (2013) 113:1004-12. doi:10.1161/CIRCRESAHA.113.301198
5. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 2:965-75. doi:10.1038/nri957
6. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol (2010) 189:1059-70. doi:10.1083/jcb.201004096
7. Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6:280-9. doi:10.1038/nrrheum.2010.46
8. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science (2004) 304:1147-50. doi:10.1126/science.1094359
9. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 411:207-11. doi:10.1038/35079659
10. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 19:56-9. doi:10.1038/ng0598-56
11. Ramirez-Ortiz ZG, Pendergraft WF III, Prasad A, Byrne MH, Iram T, Blanchette CJ, et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol (2013) 14:917-26. doi:10.1038/ni.2670
12. Szondy Z, Sarang Z, Molnar P, Nemeth T, Piacentini M, Mastroberardino PG, et al. Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci U S A (2003) 100:7812-7. doi:10.1073/pnas.0832466100
13. Lewis MJ, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity (2006) 39:367-78. doi:10.1080/08916930600739233
14. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol (2008) 294:L601-11. doi:10.1152/ajplung.00320.2007
15. McCubbrey AL, Curtis JL. Efferocytosis and lung disease. Chest (2013) 143:1750-7. doi:10.1378/chest.12-2413
16. Seimon T, Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res (2009) 50(Suppl):S382-7. doi:10.1194/jlr.R800032-JLR200
17. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol (2008) 28:1421-8. doi:10.1161/ATVBAHA.108.167197
18. Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol (2007) 170:416-26. doi:10.2353/ajpath.2007.060406
19. Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol (2006) 26:563-9. doi:10.1161/01.ATV.0000203503.82693.c1
20. Moura R, Tjwa M, Vandervoort P, Van Kerckhoven S, Holvoet P, Hoylaerts MF. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice. Circ Res (2008) 103:1181-9. doi:10.1161/CIRCRESAHA.108.185645
21. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol (2000) 1:120-9. doi:10.1038/35040009
22. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci (2006) 9:917-24. doi:10.1038/nn1715
23. O'Brien BA, Fieldus WE, Field CJ, Finegood DT. Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats. Cell Death Differ (2002) 9:457-64. doi:10.1038/sj.cdd.4400973
24. Li S, Sun Y, Liang CP, Thorp EB, Han S, Jehle AW, et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res (2009) 105:1072-82. doi:10.1161/CIRCRESAHA.109.199570
25. Lauber K, Bohn E, Kröber SM, Xiao YJ, Blumenthal SG, Lindemann RK, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 113:717-30. doi:10.1016/S0092-8674(03)00422-7
26. Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood (2008) 112:5026-36. doi:10.1182/blood-2008-06-162404
27. Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. FASEB J (2008) 22:2629-38. doi:10.1096/fj.08-107169
28. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature (2009) 461:282-6. doi:10.1038/nature08296
29. Moodley Y, Rigby P, Bundell C, Bunt S, Hayashi H, Misso N, et al. Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am J Pathol (2003) 162:771-9. doi:10.1016/S0002-9440(10)63874-6
30. Wakasugi K, Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science (1999) 284:147-51. doi:10.1126/science.284.5411.147
31. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature (2007) 450:435-9. doi:10.1038/nature06307
32. Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH, et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ (2008) 15:192-201. doi:10.1038/sj.cdd.4402242
33. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature (2007) 450:430-4. doi:10.1038/nature06329
34. Chen J, Carey K, Godowski PJ. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene (1997) 14:2033-9. doi:10.1038/sj.onc.1201039
35. Hall MO, Obin MS, Heeb MJ, Burgess BL, Abrams TA. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp Eye Res (2005) 81:581-91. doi:10.1016/j.exer.2005.03.017
36. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest (1992) 90:1513-22. doi:10.1172/JCI116019
37. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature (2002) 417:182-7. doi:10.1038/417182a
38. Tóth B, Garabuczi E, Sarang Z, Vereb G, Vámosi G, Aeschlimann D, et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol (2009) 182:2084-92. doi:10.4049/jimmunol.0803444
39. Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem (2012) 287:33733-44. doi:10.1074/jbc.M112.341339
40. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 194:781-95. doi:10.1084/jem.194.6.781
41. Thomas L, Bielemeier A, Lambert PA, Darveau RP, Marshall LJ, Devitt A. The N-terminus of CD14 acts to bind apoptotic cells and confers rapid-tethering capabilities on non-myeloid cells. PLoS One (2013) 8:e70691. doi:10.1371/journal.pone.0070691
42. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell (2005) 123:321-34. doi:10.1016/j.cell.2005.08.032
43. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature (2002) 418:200-3. doi:10.1038/nature00811
44. Nakaya M, Tanaka M, Okabe Y, Hanayama R, Nagata S. Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages. J Biol Chem (2006) 281:8836-42. doi:10.1074/jbc.M510972200
45. Kinchen JM, Cabello J, Klingele D, Wong K, Feichtinger R, Schnabel H, et al. Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature (2005) 434:93-9. doi:10.1038/nature03263
46. Wu Y, Singh S, Georgescu MM, Birge RB. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci (2005) 118:539-53. doi:10.1242/jcs.01632
47. Albert ML, Kim JI, Birge RB. Alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nat Cell Biol (2000) 2:899-905. doi:10.1038/35046549
48. Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, Tosello-Trampont AC, et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol (2002) 4:574-82. doi:10.1038/ncb824
49. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, et al. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem (2002) 277:11772-9. doi:10.1074/jbc.M109336200
50. Park SY, Kang KB, Thapa N, Kim SY, Lee SJ, Kim IS. Requirement of adapter protein GULP-6 for stabilin-2 mediated cell corpse engulfment. J Biol Chem (2008) 283:10593-600. doi:10.1074/jbc.M709105200
51. Zou W, Wang X, Vale RD, Ou G. Autophagy genes promote apoptotic cell corpse clearance. Autophagy (2012) 8:1267-8. doi:10.4161/auto.20786
52. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P, et al. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci U S A (2011) 108:17396-401. doi:10.1073/pnas.1113421108
53. Xu M, Liu Y, Zhao L, Gan Q, Wang X, Yang C. The lysosomal cathepsin protease CPL-1 plays a leading role in phagosomal degradation of apoptotic cells in Caenorhabditis elegans. Mol Biol Cell (2014) 25(13):2071-83. doi:10.1091/mbc.E14-01-0015
54. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature (2006) 443:998-1002. doi:10.1038/nature05245
55. Kiss RS, Elliott MR, Ma Z, Marcel YL, Ravichandran KS. Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. Curr Biol (2006) 16:2252-8. doi:10.1016/j.cub.2006.09.043
56. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A (2000) 97:12097-102. doi:10.1073/pnas.200367697
57. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 7:161-71. doi:10.1016/S1097-2765(01)00164-2
58. Park D, Han CZ, Elliott MR, Kinchen JM, Trampont PC, Das S, et al. Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein. Nature (2011) 477:220-4. doi:10.1038/nature10340
59. Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, et al. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med (2009) 15:1266-72. doi:10.1038/nm.2048
60. Roszer T, Menéndez-Gutiérrez MP, Lefterova MI, Alameda D, Núñez V, Lazar MA, et al. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2011) 186:621-31. doi:10.4049/jimmunol.1002230
61. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity (2009) 31:245-58. doi:10.1016/j.immuni.2009.06.018
62. Garabuczi é, Kiss B, Felszeghy S, Tsay GJ, Fésüs L, Szondy Z. Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes. Amino Acids (2013) 44:235-44. doi:10.1007/s00726-011-1119-4
63. Sarang Z, Joós G, Rühl R, Gregory CD, Garabuczi E, Szondy Z. Macrophages engulfing apoptotic cells produce non-classical retinoids to enhance their phagocytic capacity. J Immunol (2014) 192(12):5730-8. doi:10.4049/jimmunol.1400284
64. Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled to specific recognition. J Immunol (2004) 172:880-9. doi:10.4049/jimmunol.172.2.880
65. Kidani Y, Bensinger SJ. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev (2012) 249:72-83. doi:10.1111/j.1600-065X.2012.01153.x
66. Ipseiz N, Uderhardt S, Scholtysek C, Steffen M, Schabbauer G, Bozec A, et al. The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells. J Immunol (2014) 192:4852-8. doi:10.4049/jimmunol.1303377
67. McDonald PP, Fadok VA, Bratton D, Hanson PM. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-ß in macrophages that have ingested apoptotic cells. J Immunol (1999) 163:6164-72.
68. Köröskényi K, Duró E, Pallai A, Sarang Z, Kloor D, Ucker DS, et al. Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol (2011) 186:7144-55. doi:10.4049/jimmunol.1002284
69. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol (2010) 41:366-79. doi:10.1002/eji.201040801
70. Uderhardt S, Krönke G. 12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. J Mol Med (2012) 90:1247-56. doi:10.1007/s00109-012-0954-4
71. Pashover-Schallinger E, Aswad M, Schif-Zuck S, Shapiro H, Singer P, Ariel A. The atypical chemokine receptor D6 controls macrophage efferocytosis and cytokine secretion during the resolution of inflammation. FASEB J (2012) 26:3891-900. doi:10.1096/fj.11-194894
72. Otani A, Ishihara S, Aziz MM, Oshima N, Mishima Y, Moriyama I, et al. Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis. Int J Mol Med (2012) 29:349-56. doi:10.3892/ijmm.2011.866
73. Aziz MM, Ishihara S, Rumi MA, Mishima Y, Oshima N, Kadota C, et al. Prolactin induces MFG-E8 production in macrophages via transcription factor C/EBPbeta-dependent pathway. Apoptosis (2008) 13:609-20. doi:10.1007/s10495-008-0201-1
74. Lauber K, Keppeler H, Munoz LE, Koppe U, Schröder K, Yamaguchi H, et al. Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ (2013) 20:1230-40. doi:10.1038/cdd.2013.82
75. Schutters K, Kusters DH, Chatrou ML, Montero-Melendez T, Donners M, Deckers NM, et al. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells. Cell Death Differ (2013) 20:49-56. doi:10.1038/cdd.2012.107
76. Khalifeh-Soltani A, McKleroy W, Sakuma S, Cheung YY, Tharp K, Qiu Y, et al. Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids. Nat Med (2014) 20:175-83. doi:10.1038/nm.3450
77. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C, et al. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol (2009) 183:2167-75. doi:10.4049/jimmunol.0803503
78. Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 178:139-48. doi:10.1164/rccm.200711-1666OC
79. Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother (2003) 47:48-53. doi:10.1128/AAC.47.1.48-53.2003
80. Maderna P, Yona S, Perretti M, Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J Immunol (2005) 174:3727-33. doi:10.4049/jimmunol.174.6.3727
81. Zahuczky G, Kristóf E, Majai G, Fésüs L. Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS One (2011) 6:e21349. doi:10.1371/journal.pone.0021349
82. Majai G, Sarang Z, Csomós K, Zahuczky G, Fésüs L. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol (2007) 37:1343-54. doi:10.1002/eji.200636398
83. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A (2002) 99:7604-9. doi:10.1073/pnas.112059299
84. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med (2003) 9:213-9. doi:10.1038/nm820
85. Sodhi RK, Singh N. Liver X receptors: emerging therapeutic targets for Alzheimer's disease. Pharmacol Res (2013) 72:45-51. doi:10.1016/j.phrs.2013.03.008
86. Im SS, Osborne TF. Liver X receptors in atherosclerosis and inflammation. Circ Res (2011) 108:996-1001. doi:10.1161/CIRCRESAHA.110.226878
87. Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, et al. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res (2009) 50:312-26. doi:10.1194/jlr.M800376-JLR200
88. Loren J, Huang Z, Laffitte BA, Molteni V. Liver X receptor modulators: a review of recently patented compounds (2009-2012). Expert Opin Ther Pat (2013) 23:1317-35. doi:10.1517/13543776.2013.814640
89. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med (1998) 217:263-73. doi:10.3181/00379727-217-44231
90. Ronis MJ, Chen Y, Badeaux J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr (2009) 139:1431-8. doi:10.3945/jn.109.107029
91. Rébé C, Raveneau M, Chevriaux A, Lakomy D, Sberna AL, Costa A, et al. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages. Circ Res (2009) 105:393-401. doi:10.1161/CIRCRESAHA.109.201855
92. Yen JH, Yang DJ, Chen MC, Yi-Ying W, Hsieh YF, Cheng YM, et al. Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity. Mol Immunol (2014) 60:135-42. doi:10.1016/j.molimm.2014.04.006
93. Belvisi MG, Hele DJ. Peroxisome proliferator-activated receptors as novel targets in lung disease. Chest (2008) 134:152-7. doi:10.1378/chest.08-0019
94. Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL. PPAR? activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood (2010) 116:4512-22. doi:10.1182/blood-2010-02-272005
95. Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, et al. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol (2002) 51:694-702. doi:10.1002/ana.10206
96. Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, et al. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 168:65-75. doi:10.1016/j.jneuroim.2005.07.006
97. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J Immunol (2003) 170:5793-8. doi:10.4049/jimmunol.170.11.5793
98. Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int (2004) 66:1018-28. doi:10.1111/j.1523-1755.2004.00850.x
99. Kinoshita K, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S, et al. Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis (2010) 55:344-7. doi:10.1053/j.ajkd.2009.06.012
100. Walsh SJ, Algert C, Gregorio DI, Reisine ST, Rothfield NF. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol (1995) 22:1663-8.
101. Giles KM, Ross K, Rossi AG, Hotchin NA, Haslett C, Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J Immunol (2001) 167:976-86. doi:10.4049/jimmunol.167.2.976
102. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 164:1663-7. doi:10.4049/jimmunol.164.4.1663
103. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 8:349-61. doi:10.1038/nri2294
104. Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol (2004) 5:388-92. doi:10.1038/ni1056
105. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, et al. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol (2006) 176:7657-65. doi:10.4049/jimmunol.176.12.7657
106. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res (2007) 100:1442-51. doi:10.1161/01.RES.0000268411.49545.9c
107. Moon C, Lee YJ, Park HJ, Chong YH, Kang JL. N-acetylcysteine inhibits RhoA and promotes apoptotic cell clearance during intense lung inflammation. Am J Respir Crit Care Med (2010) 181:374-87. doi:10.1164/rccm.200907-1061OC
108. McPhee CK, Logan MA, Freeman MR, Baehrecke EH. Activation of autophagy during cell death requires the engulfment receptor Draper. Nature (2010) 465:1093-6. doi:10.1038/nature09127
109. Romao S, Münz C. LC3-associated phagocytosis. Autophagy (2014) 10:526-8. doi:10.4161/auto.27606
110. Zang L, Xu Q, Ye Y, Li X, Liu Y, Tashiro S, et al. Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. Arch Biochem Biophys (2012) 518:31-41. doi:10.1016/j.abb.2011.11.019
111. Hartford CM, Ratain MJ. Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin Pharmacol Ther (2007) 82:381-8. doi:10.1038/sj.clpt.6100317
112. Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science (2010) 329:229-32. doi:10.1126/science.1190354
113. Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S, Sadiq O, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet (2010) 19:2144-53. doi:10.1093/hmg/ddq093
114. Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 11:1305-14. doi:10.1038/ncb1975
115. Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, et al. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy (2010) 6:186-8. doi:10.4161/auto.6.1.10817
116. Morselli E, Mariño G, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol (2011) 192:615-29. doi:10.1083/jcb.201008167
117. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov (2006) 5:493-506. doi:10.1038/nrd2060
118. Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O, et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med (2002) 196:1553-61. doi:10.1084/jem.20020263
119. Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol (2013) 4:632-40. doi:10.1016/j.coph.2013.05.012